The US Centers for Medicare & Medicaid Services (CMS) has created of a new technology International Classification of Diseases, Revision 10 (ICD-10) code for a nanotextured surface on an interbody fusion device.
Titan Spine have announced that the company’s nanoLOCK surface technology—which was cleared by the US Food and Drug Administration in 2014 for interbody fusion devices—has been given access to use this code.
The “Interbody Fusion Device, Nanotextured Surface” code was approved as an XRG code by CMS and will be able to be used starting October 1, 2016.
According to a company release, this code was approved based on information presented by Titan Spine on its nanoLOCK surface, demonstrating it as a differentiated technology. Other technologies may be added to this code but must first either demonstrate equivalence to nanoLOCK, or demonstrate superiority to all other market alternatives through the CMS designated processes.
In late 2015, Titan Spine completed the CMS New Technology Procedural Coding System Application and ICD-10 Code Request, which was supported in early 2016 through two CMS Public Forums: i) the CMS New Technology Add-On Payment Town Hall and ii) the CMS ICD-10 Coordination & Maintenance Committee. The culmination of these steps resulted in a Section X New Technology ICD-10 code which aligns hospital coding to nanoLOCK’s product distinctiveness.
